FMC News & Events

FMC and Tessenderlo Group announced that they have entered into a definitive agreement under which Tessenderlo Group will make a strategic minority equity investment in FMC Corporation of approximately $400M at a price of $13.30 per share. Upon completion of the transaction, Tessenderlo Group will own approximately 20% of the outstanding shares of FMC common stock. This transaction represents the conclusion of the FMC Board of Directors' exploration of strategic options, which was announced in February. FMC intends to use the funds to pay down debt, allowing the company to reach its approximately $1B debt paydown target. The closing of the transaction is subject to customary conditions, including the receipt of regulatory approvals.

FMC has entered into a framework agreement to sell its property in Newark, Delaware for gross proceeds of approximately $114M, subject to a due diligence period and other closing conditions and adjustments. Upon completion of the sale, FMC intends to lease back the facilities it actively operates under a separate lease agreement. FMC will retain ownership of its adjacent Maryland properties. The decision to pursue this transaction reflects FMC's ongoing efforts to optimize its asset base, converting underutilized real estate into capital that will be applied directly to debt reduction while maintaining the operational capabilities central to the company's growth strategy. FMC's Stine Research Center, its global R&D headquarters, will continue to operate at the site following the transaction. The company's R&D capabilities, core research activities and scientific infrastructure remain fully in place.